119 related articles for article (PubMed ID: 32599216)
1. Volume of Gadolinium Enhancement and Successful Repair of the Blood-Brain Barrier in Cerebral Adrenoleukodystrophy.
Lund TC; Ng M; Orchard PJ; Loes DJ; Raymond GV; Gupta A; Kenny-Jung D; Nascene DR
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1894-1899. PubMed ID: 32599216
[TBL] [Abstract][Full Text] [Related]
2. Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy.
Orchard PJ; Nascene DR; Miller WP; Gupta A; Kenney-Jung D; Lund TC
Blood; 2019 Mar; 133(12):1378-1381. PubMed ID: 30635285
[TBL] [Abstract][Full Text] [Related]
3. Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients.
Miller WP; Mantovani LF; Muzic J; Rykken JB; Gawande RS; Lund TC; Shanley RM; Raymond GV; Orchard PJ; Nascene DR
AJNR Am J Neuroradiol; 2016 Feb; 37(2):367-72. PubMed ID: 26427835
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.
Pierpont EI; Eisengart JB; Shanley R; Nascene D; Raymond GV; Shapiro EG; Ziegler RS; Orchard PJ; Miller WP
JAMA Neurol; 2017 Jun; 74(6):710-717. PubMed ID: 28418523
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction.
Thibert KA; Raymond GV; Nascene DR; Miller WP; Tolar J; Orchard PJ; Lund TC
PLoS One; 2012; 7(11):e50430. PubMed ID: 23185624
[TBL] [Abstract][Full Text] [Related]
6. Clinical and radiographic course of arrested cerebral adrenoleukodystrophy.
Mallack EJ; van de Stadt S; Caruso PA; Musolino PL; Sadjadi R; Engelen M; Eichler FS
Neurology; 2020 Jun; 94(24):e2499-e2507. PubMed ID: 32482842
[TBL] [Abstract][Full Text] [Related]
7. Differential outcomes for frontal versus posterior demyelination in childhood cerebral adrenoleukodystrophy.
Gupta AO; Nascene DR; Shanley R; Kenney-Jung DL; Eisengart JB; Lund TC; Orchard PJ; Pierpont EI
J Inherit Metab Dis; 2021 Nov; 44(6):1434-1440. PubMed ID: 34499753
[TBL] [Abstract][Full Text] [Related]
8. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.
Miller WP; Rothman SM; Nascene D; Kivisto T; DeFor TE; Ziegler RS; Eisengart J; Leiser K; Raymond G; Lund TC; Tolar J; Orchard PJ
Blood; 2011 Aug; 118(7):1971-8. PubMed ID: 21586746
[TBL] [Abstract][Full Text] [Related]
9. Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation.
Raymond GV; Aubourg P; Paker A; Escolar M; Fischer A; Blanche S; Baruchel A; Dalle JH; Michel G; Prasad V; Miller W; Paadre S; Balser J; Kurtzberg J; Nascene DR; Orchard PJ; Lund T
Biol Blood Marrow Transplant; 2019 Mar; 25(3):538-548. PubMed ID: 30292747
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for vision loss after hematopoietic cell transplant for X-linked adrenoleukodystrophy.
Gess A; Christiansen SP; Pond D; Peters C
J AAPOS; 2008 Jun; 12(3):273-6. PubMed ID: 18359652
[TBL] [Abstract][Full Text] [Related]
11. The Spectrum of MR Imaging Patterns Suggestive of Pediatric Posterior Reversible Encephalopathy Syndrome in Children With Cerebral X-Linked Adrenoleukodystrophy.
Ozturk K; McKinney AM
J Neuroimaging; 2020 Nov; 30(6):930-935. PubMed ID: 32770607
[TBL] [Abstract][Full Text] [Related]
12. Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy.
Orchard PJ; Markowski TW; Higgins L; Raymond GV; Nascene DR; Miller WP; Pierpont EI; Lund TC
Sci Rep; 2019 May; 9(1):7858. PubMed ID: 31133696
[TBL] [Abstract][Full Text] [Related]
13. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.
Peters C; Charnas LR; Tan Y; Ziegler RS; Shapiro EG; DeFor T; Grewal SS; Orchard PJ; Abel SL; Goldman AI; Ramsay NK; Dusenbery KE; Loes DJ; Lockman LA; Kato S; Aubourg PR; Moser HW; Krivit W
Blood; 2004 Aug; 104(3):881-8. PubMed ID: 15073029
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy.
Kühl JS; Suarez F; Gillett GT; Hemmati PG; Snowden JA; Stadler M; Vuong GL; Aubourg P; Köhler W; Arnold R
Brain; 2017 Apr; 140(4):953-966. PubMed ID: 28375456
[TBL] [Abstract][Full Text] [Related]
15. Failure of intrathecal allogeneic mesenchymal stem cells to halt progressive demyelination in two boys with cerebral adrenoleukodystrophy.
Gupta A; Orchard PJ; Miller WP; Nascene DR; Raymond GV; Loes DJ; McKenna DH; Lund TC
Stem Cells Transl Med; 2020 May; 9(5):554-558. PubMed ID: 32020747
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
Eichler F; Duncan C; Musolino PL; Orchard PJ; De Oliveira S; Thrasher AJ; Armant M; Dansereau C; Lund TC; Miller WP; Raymond GV; Sankar R; Shah AJ; Sevin C; Gaspar HB; Gissen P; Amartino H; Bratkovic D; Smith NJC; Paker AM; Shamir E; O'Meara T; Davidson D; Aubourg P; Williams DA
N Engl J Med; 2017 Oct; 377(17):1630-1638. PubMed ID: 28976817
[TBL] [Abstract][Full Text] [Related]
17. Childhood Cerebral Adrenoleukodystrophy: MR Perfusion Measurements and Their Use in Predicting Clinical Outcome after Hematopoietic Stem Cell Transplantation.
McKinney AM; Benson JC; Nascene DR; Eisengart J; Salmela MB; Loes DJ; Zhang L; Patel K; Raymond GV; Miller WP
AJNR Am J Neuroradiol; 2016 Sep; 37(9):1713-20. PubMed ID: 27079370
[TBL] [Abstract][Full Text] [Related]
18. Adrenoleukodystrophy. Value of contrast-enhanced MR imaging.
Romero C; Dietemann JL; Kurtz D; Bataillard M; Christmann D
J Neuroradiol; 1990; 17(4):267-76. PubMed ID: 2092086
[TBL] [Abstract][Full Text] [Related]
19. Time to Transplant in X-Linked Adrenoleukodystrophy.
Bonkowsky JL; Wilkes J
J Child Neurol; 2022 Apr; 37(5):397-400. PubMed ID: 35238239
[TBL] [Abstract][Full Text] [Related]
20. Cerebral adrenoleukodystrophy is associated with loss of tolerance to profilin.
Orchard PJ; Nascene DR; Gupta A; Taisto ME; Higgins L; Markowski TW; Lund TC
Eur J Immunol; 2019 Jun; 49(6):947-953. PubMed ID: 30829395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
